Canaan Partners β 2024 Investments
9 investments dated 2024 Β· listed companies and verified rows first Β· show all
Tyra is developing oral dabogratinib, a small-molecule therapy being evaluated in clinical studies for skeletal dysplasia and urologic cancers.
BiotechHealthtechCarlsbad, US
Todd Harris, Ph.D.(Executive Officer, Director)Hiroomi Tada, M.D., Ph.D.(Executive Officer)Daniel Bensen(Executive Officer)Alan Fuhrman(Executive Officer)
BoardRobert More(Director)
Board seatNina KjellsonΒ· per SEC Form D Β· $200M raise Β· filed Feb 2024
Co-investorsAlta PartnersBioBritNextech Invest
Ollie provides personalized fresh dog food recipes crafted by chefs and food scientists, paired with health monitoring services that analyze dog wellness indicators to optimize nutrition and health outcomes for pet owners.
ConsumerFoodTechNew York, US
Nick StaffordinDan Ciporin(Director)Alexandre Douzet(Executive Officer, Director)Steve Marton(Director)
BoardBenjamin Sun(Director)
Board seatLaura ChauΒ· per SEC Form D
Co-investorsARC Angel FundCorrelation VenturesDarco CapitalFelicis VenturesInterplay Ventures Early Stage Management LlcLerer Hippeau+3 more
Quantum Circuits develops superconducting quantum computers using dual-rail qubits with built-in error detection, designed to accelerate the path to fault-tolerant quantum computing.
Advanced ManufacturingDeep TechHardwareQuantum ComputingMadison, US
Rob Schoelkopf(Sterling Professor, Founder)Luigi FrunzioRay Smets
Board seatBrendan DickinsonΒ· per SEC Form D
Co-investorsARCH Venture PartnersConnecticut InnovationsF-Prime CapitalOUP (Osage University Partners)Tribeca Venture PartnersFitz Gate Ventures
RenoFi is a fintech platform that enables credit unions to offer home equity loans and HELOCs based on after-renovation property values to homeowners financing renovation and construction projects.
FintechPropTechPhiladelphia, US
Justin Goldman(Co-Founder & CEO)inRobert Shedd(Executive Officer, Director)Lee Miller(Executive Officer, Director)in
BoardSamanttabhiram Das(Director)
Board seatBrendan DickinsonΒ· per SEC Form D
Co-investorsComcast VenturesCurql Collective, LLCNext Level VenturesNycaNyca PartnersTruStage Ventures+1 more
Autobahn Therapeutics develops orally administered small molecule prodrugs using a brain-targeting chemistry platform to create regenerative medicines for central nervous system (CNS) disorders.
BiotechDeep TechMedical DevicesSan Diego, US
Kevin Finney(Chairman, President and CEO)inJohn Borkholder(Executive Officer)
BoardKristina Burow(Director)inThomas Cahill(Director)Timothy Anderson(Director)Philip J DeSouza(Director)
Co-investorsARCH Venture PartnersMonograph Capital PartnersPfizer Venture InvestmentsSamsara BioCapitalNewpath Partners
Enterpret offers a customer feedback analytics platform with dashboards and reporting that consolidate voice-of-customer data, rank themes by business impact (ARR, CSAT, NPS), and surface real-time insights.
AI & Machine LearningData & InfrastructureEnterprise SoftwareMarketing TechSaaSSan Francisco, US
Arnav S.(Founder)inArnav S(Founder)Varun Sharma(Founder)
Co-investorsInvariantes FundKleiner PerkinsPeak XV PartnersRecall CapitalUnusual VenturesiSeed
Safire develops hardware and software for energy systems, including resilient battery design, ruggedized sensing, secure communications, and an AI-powered energy operating system for real-time monitoring and control.
CleantechDefense TechEnergyHardwareMobility & Transportation
John Lee(Founder)in
Co-investorsCorrelation VenturesMaC Venture CapitalOUTPOST VENTURESAJINOMOTO CO.,INC.Automotive VenturesDangerous Ventures
BiotechWayland, US
Tim Ahfeldt(Executive Officer, Director)
BoardJoshua Lamstein(Executive Officer, Director)
Rows marked βSEC filingβ are inferred from directors named on the company's SEC Form D β public regulatory data, not a portfolio list published by the firm.